<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336810">
  <stage>Registered</stage>
  <submitdate>13/04/2011</submitdate>
  <approvaldate>14/04/2011</approvaldate>
  <actrnumber>ACTRN12611000390987</actrnumber>
  <trial_identification>
    <studytitle>Expression of molecules that detect the presence of fat in the small intestine.</studytitle>
    <scientifictitle>Identification and quantification of the fatty acid sensing molecules, CD36, GPR119, GPR120, and GPR 40 in the duodenum of lean and obese humans.</scientifictitle>
    <utrn>N/A.</utrn>
    <trialacronym />
    <secondaryid>Nil.</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Obesity</healthcondition>
    <healthcondition>Healthy human physiology</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Normal oral and gastrointestinal development and function</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Participants will undergo endoscopy (as scheduled for clinical reasons). Small intestinal biopsies will be obtained. The duration of the trial will be approximately 1 hour.</interventions>
    <comparator>Nil.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Expression of mRNA and protein of CD36, GPR119, GPR120 and GPR40 in small intestinal biopsies.</outcome>
      <timepoint>Once only.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Habitual dietary intake, as assessed by the use of a Food Frequency Questionnaire.</outcome>
      <timepoint>Once only.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients aged 18-75 years, scheduled to undergo surveillance endoscopy at the Royal Adelaide Hospital.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>-diffuse mucosal disease involving the upper gastrointestinal tract, including Crohn's disease, coeliac disease, or ischaemic changes, evident either macroscopically or on histopathological examination of mucosal biopsies, when the latter is clinically indicated.
-gastrointestinal symptoms
-ongoing anticoagulation or bleeding disorder, or use of anticoagulant drugs (e.g. aspirin, clopidogrel)</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Convenience sample</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/05/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Adelaide</primarysponsorname>
    <primarysponsoraddress>North Terrace, Adelaide, SA, 5005</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Tanya Little</sponsorname>
      <sponsoraddress>University of Adelaide Discipline of Medicine
Level 6, Eleanor Harrald Building
Royal Adelaide Hospital
North Terrace
Adelaide, SA, 5000</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of the study is to identify, and quantify, the expression of fatty acid sensing molecules, including CD36, GPR119, GPR120 and GPR40, in human duodenal biopsies.</summary>
    <trialwebsite>N/A.</trialwebsite>
    <publication>Nil.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Adelaide Hospital Research Ethics Committee</ethicname>
      <ethicaddress>Level 3, Hanson Institute
Royal Adelaide Hospital
North Terrace, Adelaide, SA, 5000</ethicaddress>
      <ethicapprovaldate>11/03/2011</ethicapprovaldate>
      <hrec>110207</hrec>
      <ethicsubmitdate>30/01/2011</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Tanya Little</name>
      <address>University of Adelaide Discipline of Medicine
Level 6, Eleanor Harrald Building
Royal Adelaide Hospital
North Terrace
Adelaide, SA, 5000</address>
      <phone>(08) 8222 0724</phone>
      <fax>(08) 8223 3870</fax>
      <email>tanya.little@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Tanya Little</name>
      <address>University of Adelaide Discipline of Medicine
Level 6, Eleanor Harrald Building
Royal Adelaide Hospital
North Terrace
Adelaide, SA, 5000</address>
      <phone>+61 8 8222 0724</phone>
      <fax>+61 8 8223 3870</fax>
      <email>tanya.little@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Tanya Little</name>
      <address>University of Adelaide Discipline of Medicine
Level 6, Eleanor Harrald Building
Royal Adelaide Hospital
North Terrace
Adelaide, SA, 5000</address>
      <phone>(08) 8222 0724</phone>
      <fax>(08) 8223 3870</fax>
      <email>tanya.little@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>